California 2025-2026 Regular Session

California Assembly Bill AB447

Introduced
2/6/25  
Refer
3/3/25  
Report Pass
3/28/25  
Refer
3/3/25  
Refer
4/1/25  
Report Pass
3/28/25  
Report Pass
4/8/25  
Refer
4/1/25  
Refer
4/10/25  
Report Pass
4/8/25  
Report Pass
4/8/25  
Report Pass
4/30/25  
Refer
4/10/25  
Refer
5/5/25  
Refer
4/10/25  
Report Pass
5/14/25  
Engrossed
5/23/25  
Refer
5/23/25  
Refer
6/4/25  
Report Pass
6/23/25  
Refer
6/23/25  
Report Pass
7/3/25  
Refer
7/3/25  

Caption

Emergency room patient prescriptions.

Impact

The bill is expected to streamline the process of patient care within emergency departments by allowing prescribers to directly provide medications needed after discharge. This could reduce the barriers where patients might otherwise have to visit a pharmacy for leftover medication, especially during off-hours when pharmacies are closed. The changes could enhance continuity of care for patients while alleviating pressures on pharmacy staffing in emergency situations.

Summary

AB447, introduced by Assembly Member Mark Gonzlez, amends sections of the Business and Professions Code concerning the dispensing of dangerous drugs to emergency room patients. The bill permits prescribers to dispense an unused portion of dangerous drugs obtained from a hospital pharmacy to emergency room patients upon discharge under specific conditions. Notably, these drugs cannot be controlled substances and must be necessary for the patient's continued treatment after leaving the emergency room.

Sentiment

Sentiments expressed during discussions surrounding AB447 appear to be generally supportive among healthcare providers who recognize the practical benefits of enabling quick access to essential drugs for patients leaving emergency care. However, there may be concerns regarding potential misuse or errors in dispensing as the prescriber bears responsibility for any mistakes related to the drugs dispensed, indicating a necessity for clear communication and protocols.

Contention

Notable points of contention revolve around the responsibilities imposed on prescribers under the new provisions, such as ensuring accurate labeling and adherence to the established limits on dispensing. Opponents may argue that this could lead to safety concerns if not managed effectively, especially regarding patients’ understanding of how to self-administer medications properly. Additionally, discussions may touch on the broader implications for pharmacy practices and the regulatory landscape.

Companion Bills

No companion bills found.

Previously Filed As

CA AB1399

Veterinary medicine: veterinarian-client-patient relationship: telehealth.

CA AB1557

Pharmacy: electronic prescriptions.

CA SB816

Professions and vocations.

CA SB669

Veterinarians: veterinarian-client-patient relationship.

CA SB524

Pharmacists: furnishing prescription medications.

CA AB1286

Pharmacy.

CA AB1902

Prescription drug labels: accessibility.

CA SB667

Healing arts: pregnancy and childbirth.

CA AB1316

Emergency services: psychiatric emergency medical conditions.

CA AB1751

Opioid prescriptions: information: nonpharmacological treatments for pain.

Similar Bills

CA AB1503

Pharmacy.

CA AB1286

Pharmacy.

CA AB1533

Pharmacy.

CA SB1447

Pharmacy: automated drug delivery systems.

CA SB617

Pharmacy technicians: supervision.